Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Paget Disease: Chaotic Bone Remodeling and Periosteal Pain
Paget disease of bone is the second most common metabolic bone disorder, surpassed only by osteoporosis. It affects 2%–3% of the population over 55 years of age, with higher prevalence in men and in descendants of northern Europeans. It is characterized by hyperactivation of osteoclasts, which begin to resorb bone in an accelerated and disordered manner — followed by equally disorganized osteoblastic deposition. The result is an expanded, hypervascularized, larger bone, but structurally fragile and prone to deformities and pathologic fractures.
Pain in Paget is multifactorial: direct periosteal pain from increased vascularization and intraosseous pressure; compensatory muscle spasmaround the expanded bone segment; neurologic compression from expansion of pagetic bone over adjacent nerve structures; and secondary arthritisin joints adjacent to the Paget focus (pagetic coxarthrosis, pagetic gonarthrosis). Elevated alkaline phosphatase (AP) is the laboratory marker of disease activity.
Conventional Treatments: Bisphosphonates as the Gold Standard
The definitive treatment of active Paget is suppression of osteoclasts with bisphosphonates. IV zoledronate (5 mg in a single dose) is the gold standard: it normalizes alkaline phosphatase in 89% of patients, with sustained remission for up to 6 years in many cases. Oral alendronate (40 mg/day for 6 months) is an effective alternative for moderate cases. With adequate treatment, bone remodeling normalizes in 6–12 months and direct periosteal pain — caused by hypervascularization — tends to improve.
THERAPEUTIC OPTIONS FOR PAIN IN PAGET DISEASE
| TREATMENT | INDICATION | LIMITATION |
|---|---|---|
| IV zoledronate (5 mg) | Gold standard: suppresses osteoclastic activity, improves periosteal pain in 6–12 months | Contraindicated in GFR <35 mL/min; post-infusion acute-phase reaction; cost |
| Alendronate 40 mg/day | Moderate Paget; oral alternative to zoledronate | Gastrointestinal intolerance; lower efficacy than zoledronate |
| NSAIDs (ibuprofen, naproxen) | Acute pain control / exacerbations | Nephrotoxic (problematic in Paget with renal involvement); GI risk; chronic use limited |
| Calcitonin (subcutaneous) | Historical; rarely used today | Inferior to bisphosphonates; parenteral administration; temporary effect |
| Surgery | Pathologic fractures, spinal stenosis with neurologic deficit | Surgery on pagetic bone: increased bleeding from hypervascularization |
| Acupuncture | Complementary: residual pain after bisphosphonate, compensatory muscle spasm, neuropathic pain from compression | Does not alter AP, does not modify underlying disease; limited evidence (small studies) |
How Acupuncture Works on Pain in Paget
Acupuncture does not interfere with the osteoclastic process of Paget, but acts on multiple analgesic and muscular mechanisms that represent important sources of patient suffering, even after disease activity is controlled with bisphosphonates.
Mechanisms of Action in Paget Disease
Opioidergic Periosteal Analgesia
BL-11 (the influential point of the bones) activates encephalinergic spinal interneurons that reduce periosteal nociceptive transmission. ST-36 and LI-4 activate the descending noradrenergic and serotonergic pain inhibition.
Control of Compensatory Muscle Spasm
Expanded pagetic bone alters local biomechanics, generating spasm in adjacent muscles (paravertebrals, gluteals, hamstrings). Local needling with 2 Hz EA relaxes the spastic muscle via the spino-bulbo-spinal reflex.
Modulation of Neuropathic Pain from Compression
When bone expansion compresses nerve roots (vertebral Paget) or the auditory nerve (cranial Paget), peripheral electroacupuncture reduces central sensitization and ectopic discharge of injured C and Aδ fibers.
Improvement of Secondary Arthritis
Joints adjacent to the Paget focus develop accelerated osteoarthritis. Acupuncture protocols for osteoarthritis (LI-4, GB-34, local points) have established efficacy and are applicable to pagetic arthritis.
Main Points and Their Rationale
BL11 — Influential Point of the Bones
Located at T1, it is the influence (Hui) point over the bones in Chinese medicine. It activates spinal opioidergic pathways that modulate deep periosteal nociception — the most characteristic pain of active Paget.
ST36 — Systemic Analgesia and Anti-inflammatory
The most-studied point in neuromodulation: releases β-endorphin, reduces local IL6 and TNF-α. In Paget with secondary arthritis in the knee, ST36 + ST35 reduces synovitis.
Scientific Evidence
The specific evidence for acupuncture in Paget disease of bone is limited in volume (few clinical trials, small samples), but methodologically consistent: acupuncture reduces pain and improves function without altering markers of disease activity (AP, P1NP, CTX). Good-quality studies in pagetic osteoarthritis and neuropathic pain from pagetic vertebral compression complement the body of evidence.
Modern Approach: When Acupuncture Has a Special Role in Paget
Two clinical scenarios make acupuncture particularly valuable in Paget disease of bone, where the usual pharmacologic options are limited:
Paget + Chronic Renal Failure
Zoledronate is contraindicated in GFR <35 mL/min. NSAIDs are nephrotoxic. Oral alendronate requires adjustment. Acupuncture offers analgesia without renal burden, being especially valuable in Paget with associated renal disease.
Residual Pain After Bisphosphonate Treatment
In many patients, zoledronate normalizes AP but musculoskeletal pain persists — due to established muscle spasm, secondary arthritis, or neuropathic pain from compression. In these cases, acupuncture acts on the components not addressed by the bisphosphonate.
When to See a Medical Acupuncturist
Evaluation by a medical acupuncturist should be considered in patients with symptomatic Paget in the following situations:
Main Indications
Persistent periosteal pain after 3+ months of bisphosphonate; muscle spasm refractory to NSAIDs; secondary arthritis (pagetic coxarthrosis, gonarthrosis); radicular compression from vertebral Paget; Paget + renal failure (NSAIDs contraindicated).
Contraindications and Precautions
Acute pathologic fracture in pagetic bone (await consolidation); suspicion of osteosarcoma (rapidly growing pain + AP increase + new lytic lesion); cranial Paget with expanded calvaria: avoid needling over hypervascularized pagetic calvaria.
Frequently Asked Questions
Frequently Asked Questions
No. Elevated alkaline phosphatase is a marker of osteoclastic activity — it normalizes only with bisphosphonates (zoledronate, alendronate) that directly suppress bone turnover. Specific studies in Paget confirm that acupuncture does not alter AP. Acupuncture treats pain and muscle spasm — not the underlying disease.
Needling over the expanded pagetic bone is not recommended, especially at sites with evident hypervascularization (local warmth, palpable pulsation). Needling is performed in the muscles adjacent to the affected bone. Acupuncture needles are 0.20 mm in diameter and do not cause fracture, but the risk of local hematoma in hypervascularized bone justifies the precaution.
Yes. Acupuncture can be initiated at any point in the disease course for pain control. However, zoledronate should be indicated by the rheumatologist when there is active Paget (AP >3x the upper limit of normal), as it treats the underlying disease and may improve periosteal pain in 6–12 months. The treatments are complementary and without interference.
Yes. Acupuncture is especially valuable in this context, since the usual pharmacologic treatments have renal restrictions: zoledronate is contraindicated in GFR <35 mL/min, and NSAIDs are nephrotoxic. Acupuncture offers effective analgesia without renal burden — without metabolism, excretion, or renal toxicity. It is one of the situations where its clinical role is most relevant.